AGEN
Agenus Inc.
Halal Rating :
See Details
Last Price
$13.04
Last updated:
Market Cap
$267.27m
7D Change
11.55%
1 Year Change
-57.39%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
March 14, 2024
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company is headquartered in Lexington, Massachusetts.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Dec. 31, 2023 | $83.7m | $136.48m | - | $44.57m | 0.00% | 32.66% |
| Sept. 30, 2023 | $24.31m | $89.29m | - | $18.63m | 0.00% | 20.87% |
| June 30, 2023 | $25.3m | $99.6m | - | $19.65m | 0.00% | 19.73% |
Company Impact
Help us evaluate Agenus Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.